New treatment option for Chronic Kidney Disease Stage 5
Official title CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients
ClinicalTrials.gov ID: NCT05726526
What this study is testing
- What it's testing
- The main purpose of this trial is to determine whether the addition of the VIEWER virtual care platform to usual care will lead to a reduction in composite emergency department (ED) visits and/or hospitalizations/or increase the perceived safety of virtual care among patients and providers.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- \>18 years of age
- Patient or primary caregiver can read and speak English
- Patient or patients substitute decision maker is able to provide informed consent
- Patient or primary care giver cognitively and physically capable and willing to use the VIEWER mobile application and perform self-measurements (i.e...
- Have stage 5 CKD (2 measurements of eGFR \ 40% chance of beginning dialysis in the next 2 years based on the Kidney Failure Risk Equation
You likely can't join if
- Inability of self or caregiver assisted self-monitoring using VIEWER
See the full eligibility criteria
- \>18 years of age
- Patient or primary caregiver can read and speak English
- Patient or patients substitute decision maker is able to provide informed consent
- Patient or primary care giver cognitively and physically capable and willing to use the VIEWER mobile application and perform self-measurements (i.e. weight, BP, etc.)
- Have stage 5 CKD (2 measurements of eGFR \ 40% chance of beginning dialysis in the next 2 years based on the Kidney Failure Risk Equation
- Followed in a multidisciplinary CKD clinic
- Inability of self or caregiver assisted self-monitoring using VIEWER
The study team makes the final eligibility decision.
Where it's taking place
- Winnipeg, Manitoba, Canada
- London, Ontario, Canada
- Scarborough Village, Ontario, Canada
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Winnipeg, Manitoba, Canada; London, Ontario, Canada; Scarborough Village, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.